EX-23.1 3 tv486893_ex23-1.htm EXHIBIT 23.1

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-208004) and on Form S-8 (No. 333-148983, No. 333-182677 and No. 333-203960) of Protalix BioTherapeutics, Inc. of our report dated March 6, 2018, relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ Kesselman & Kesselman |
Kesselman & Kesselman |
Certified Public Accountants (lsr.) |
A member firm of PricewaterhouseCoopers International Limited
Tel-Aviv, Israel |
March 6, 2018 |